C
Clive Rosendorff
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 193
Citations - 4737
Clive Rosendorff is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Blood pressure & Coronary artery disease. The author has an hindex of 32, co-authored 193 publications receiving 4330 citations. Previous affiliations of Clive Rosendorff include University of the Witwatersrand & Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
Clive Rosendorff,Henry R. Black,Christopher P. Cannon,Bernard J. Gersh,Joel M. Gore,Joseph L. Izzo,Norman M Kaplan,Christopher M. O'Connor,Patrick T. O'Gara,Suzanne Oparil +9 more
TL;DR: The optimal choice of antihypertensive agents remains controversial, and there are only partial answers to important questions in the treatment of hypertension in the prevention and management of ischemic heart disease (IHD).
Journal ArticleDOI
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association
Biykem Bozkurt,David Aguilar,Anita Deswal,Sandra B. Dunbar,Gary S. Francis,Tamara B. Horwich,Mariell Jessup,Mikhail Kosiborod,Allison M. Pritchett,Kumudha Ramasubbu,Clive Rosendorff,Clyde W. Yancy +11 more
TL;DR: The intent of this AHA scientific statement is to summarize data relevant to contributory risk and to provide guidance on the management of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in the development and prognosis of HF to provide recommendations.
Journal ArticleDOI
Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension
Clive Rosendorff,Daniel T. Lackland,Matthew A. Allison,Wilbert S. Aronow,Henry R. Black,Roger S. Blumenthal,Christopher P. Cannon,James A. de Lemos,William J. Elliott,Laura K. Findeiss,Bernard J. Gersh,Joel M. Gore,Daniel Levy,Janet B. Long,Christopher M. O'Connor,Patrick T. O'Gara,Gbenga Ogedegbe,Suzanne Oparil,William B. White +18 more
TL;DR: 1. Relationship Between Hypertension and CAD e437, 2. Prevention of Cardiovascular Events in Patients With Hypertensions and CAD and 3. Management ofhypertension in patients With ACS e451.
Journal ArticleDOI
Treatment of Hypertension in Patients With Coronary Artery Disease A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension
Clive Rosendorff,Daniel T. Lackland,Matthew A. Allison,Wilbert S. Aronow,Henry R. Black,Roger S. Blumenthal,Christopher P. Cannon,James A. de Lemos,William J. Elliott,Laura K. Findeiss,Bernard J. Gersh,Joel M. Gore,Daniel Levy,Janet B. Long,Christopher M. O'Connor,Patrick T. O'Gara,Gbenga Ogedegbe,Suzanne Oparil,William B. White +18 more
TL;DR: The relationship between hypertension and CAD is discussed in this paper, where the authors discuss the management of hypertension in patients with CAD and Stable Angina (SANG) with the aim to prevent cardiovascular events.
Journal ArticleDOI
Cardiovascular risk factors for Alzheimer's disease.
TL;DR: The common pathogenetic mechanisms for the generation of both atherosclerotic disease and AD, such as inflammation and thegeneration of free radicals, suggest a causal link and the identification of modifiable risk factors for dementia becomes a research priority and early intervention aimed at reducing those cardiovascular risk factors a therapeutic imperative.